October is National Breast Cancer Awareness Month. As the federal government's leading funder of breast cancer research, the National Cancer Institute supports a wide range of research to improve prevention, detection, and treatment of breast cancer. NCI also funds research on follow-up care for the growing number of breast cancer survivors. Take a look at some recent advances and selected resources, including a video.
Understanding Breast Changes discusses common breast changes at various times of life, types of follow-up testing, and types of biopsies. It helps women understand their screening results and emphasizes that not all breast changes mean cancer.
Estimating Breast Cancer Risk describes the Breast Cancer Risk Assessment Tool, an online tool developed by NCI and others to help health care providers estimate a woman's individual risk of breast cancer.
The Breast Cancer Prevention Summary (PDQ®) provides an overview of factors that may raise or lower your risk of breast cancer. There is also information about clinical trials that study ways to lower the risk of developing breast cancer.
Improving mammography is the goal of the NCI-supported Breast Cancer Surveillance Consortium (BCSC), which gathers and pools data from around the country into a centralized database on women undergoing mammography.
The NCI factsheet Adjuvant and Neoadjuvant Therapy for Breast Cancerexplains side effects, risks, and benefits of two different types of breast cancer therapy. Adjuvant therapy is treatment given after primary therapy to increase the chance of long-term survival. Neoadjuvant therapy is treatment given before primary therapy.
Weekly Paclitaxel Improves Breast Cancer Survival summarizes the results of a randomized clinical trial showing that weekly doses of the drug paclitaxel (Taxol®) after surgery and standard chemotherapy improves disease-free and overall survival in women with breast cancer.
"Targeted Therapies for Breast Cancer" is an animatedtutorial focusing on targeted therapies that have been and are being developed to treat breast cancer. It describes important molecular pathways in breast cancer cells and discusses new therapeutic agents, including small molecules and monoclonal antibodies that target these pathways.
Lymphedema, a condition in which lymph fluid builds up in damaged soft body tissues and causes swelling, can be a painful side effect of breast cancer treatment.
For information about this condition, see the Lymphedema (PDQ®) summary.
Order a free copy (either a DVD or video) of "Moving Beyond Breast Cancer," featuring stories about breast cancer survivors who share their concerns and perspectives to help other women know what to expect.
Slowly progressive weight lifting did not aggravate limb swelling among breast cancer survivors with lymphedema, according to a randomized clinical trial (see the story).
Cognitive changes associated with chemotherapy for breast cancer and other kinds of cancer may, in about 20 percent of survivors, persist after treatment has ended. See Delving into Possible Mechanisms for Chemobrain in the NCI Cancer Bulletin.
Other NCI resources related to cancer survivorship include
A Snapshot of Breast Cancer provides key information about disease incidence and mortality, NCI funding trends, relevant research activities, and recent scientific advances.
Questions about cancer?
To talk with someone in English or Spanish, call 1-800-4-CANCER (1-800-422-6237), Monday through Friday, 9:00 a.m. to 4:30 p.m. local time; TTY: 1-800-332-8615.